A pioneering research study published today in Cell Metabolism details how the hormone FGF21 (fibroblast growth factor 21) ...

A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) up to 16 ...

Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...

Researchers at the University of Oklahoma report a hormone, FGF21, may reverse fatty liver disease by signaling the brain.

MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD), which was previously known as ...

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

Metabolic liver disease might not get as much attention as heart disease or diabetes, but it affects around one in four ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...